Profile of:

Sjef Van der Linden


Recent publications 1: Li Z, Khan MK, Villiger PM, van der Linden S, Brown MA, Khan MA. Reply to Niv Ben-Shabat: Mortality in AS according to treatment. Arthritis Care Res (Hoboken). 2021 Aug 26. doi: 10.1002/acr.24773. Epub ahead of print. PMID: 34437771. 2. van der Linden S et al. in: Kelley & Firestein’s Textbook of Rheumatology (11th edition). Chapter 80 – Ankylosing Spondylitis (pp 1319-1343). Elsevier, Philadelphia, 2020 3 : Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol. 2020 Dec 23. doi: 10.1038/s41584-020-00552-4. Epub ahead of print. PMID: 33361770. 4. Khan, MA, van der Linden S: Axial Spondyloarthritis: a better name for an old disease. A step toward uniform reporting. ACR Open 1:336-9, 2019 5. van der Linden S et al. in: Kelley & Firestein’s Textbook of Rheumatology (10th edition). Chapter 75 – Ankylosing Spondylitis (pp 1256-79). Elsevier, Philadelphia, 2017 6. van der Linden S, Khan MA. Axial spondyloarthritis in relatives of probands with ankylosing spondylitis: comment on the article by Turina et al. Arthritis Rheumatol 2017;69: PMID: 28002885 DOI: 10.1002/art.40026 7. van der Linden S et al. in: Kelley & Firestein’s Textbook of Rheumatology (11th edition). Chapter 80 – Ankylosing Spondylitis (pp 1319-1343). Elsevier, Philadelphia, 2020 8.: Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol. 2020 Dec 23. doi: 9.1038/s41584-020-00552-4. Epub ahead of print. PMID: 33361770. 10. Khan, MA, van der Linden S: Axial Spondyloarthritis: a better name for an old disease. A step toward uniform reporting. ACR Open 1:336-9, 2019 11. van der Linden S et al. in: Kelley & Firestein’s Textbook of Rheumatology (10th edition). Chapter 75 – Ankylosing Spondylitis (pp 1256-79). Elsevier, Philadelphia, 2017 12. van der Linden S, Khan MA. Axial spondyloarthritis in relatives of probands with ankylosing spondylitis: comment on the article by Turina et al. Arthritis Rheumatol 2017;69: PMID: 28002885 DOI: 10.1002/art.40026 13. van der Linden S, Boonen A, van Tubergen A, Vosse D, Dekker J, Dijkmans B, van der Horst-Bruinsma I, Kapinga T, van der Leeden M, van den Ende C, Hazes JM, Linssen A, Vliet Vlieland T. Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement. Clin Exp Rheumatol. 2016;34:S15-7. 14. van der Linden S, Khan MA. Can we currently and confidently assess the true burden of illness due to non-radiographic axial spondyloarthritis? Editorial. Clin Exp Rheumatol. 2016;34:963-965. 15. van der Linden S, Akkoc N, Brown MA, Robinson PC, Khan MA. The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward. Curr Rheumatol Rep. 2015;17:62.

Full name: Sjef Van der Linden

Current country: Belgium

Membership level: Full

Type of membership: Honorary

Number of publications: 0

Sjef Van der Linden did not submit any publications yet.